论文信息 - Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy - 字舞流文

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

M. Galsky | E. Heath | A. Balar | J. Rosenberg | P. O’Donnell | D. Petrylak | B. McGregor | E. Yu | N. Hahn | A. Melhem‐Bertrandt | E. Gartner | J. Pinelli | S. Liang | A. Melhem-Bertrandt